Important information

You are about to view web pages that are not intended for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Japan, Canada, Hong Kong, New Zeeland, Singapore or South Africa or any other country or jurisdiction where the release, publication or distribution of the information contained in the following web pages is subject to legal restrictions or where the offer or sale of subscription rights, paid subscription shares or new shares is not permitted. By clicking "Yes, I accept" you accept the terms of use below.

You must read the following before continuing, and you are requested to read this notice carefully (it applies to all persons who view this web page) before reading, accessing or making any other use of the information on the following pages. In accessing the following web pages, you agree to be bound by the following terms and conditions. Please note that the terms set out below may be altered or updated and you should therefore read them in full each time you visit this web site.

In certain jurisdictions, the publication or distribution of the information on the following pages may be subject to legal restrictions and all persons accessing these web pages should inform themselves about and abide by such legal restrictions.

The information on the following pages is not directed to persons located the United States, Australia, Japan, Canada, Hong Kong, New Zeeland, Singapore or South Africa or in any other country or jurisdiction where the offer or sale of subscription rights, paid subscription shares or new shares is not permitted. In addition, the information on the following pages may not be published or distributed, directly or indirectly, in or into, the United States, Australia, Japan, Canada, Hong Kong, New Zeeland, Singapore or South Africa or any other country or jurisdiction where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, other offer documentation, registrations or other actions in addition to what follows from Swedish law. Nor may the information be forwarded, reproduced or disclosed in such a manner that contravenes such restrictions or gives cause to such requirements. Failure to comply with these instructions may result in a violation of the United States Securities Act of 1933, as amended ("Securities Act") or securities regulations applicable in other jurisdictions.

The information on the following pages does not constitute an offer to acquire, sell, subscribe for or otherwise trade in shares, subscription rights or other securities in Enzymatica AB (publ) (“Enzymatica”). No action has been, or will be, taken by Enzymatica to permit a public offering in any jurisdictions other than Sweden. No subscription rights, paid subscription shares or new shares will be registered under the Securities Act and may not be offered, subscribed for, sold or transferred, directly or indirectly, within (i) the United States, except pursuant to an exemption from the registration requirements of the Securities Act, or (ii) Australia, Japan, Canada, Hong Kong, New Zeeland, Singapore or South Africa or in any other country or jurisdiction where such action would require additional prospectuses, registration or measures other than those pursuant to Swedish law.

 

While Enzymatica believes that the information posted on the following pages is accurate and complete as of the posted date, and while Enzymatica may post new information from time to time, Enzymatica does not assume any obligation to update or correct such information and explicitly disclaims any duty to do so.

In order to view the information on the following pages, you must certify that you are not located in the United States, Australia, Japan, Canada, Hong Kong, New Zeeland, Singapore or South Africa or any other country or jurisdiction where such action is wholly or partially subject to legal restrictions and that you have read, understand and agree to comply with all of the restrictions set forth above. You may do so by clicking "Yes, I accept" below. If you are located in the United States, Australia, Japan, Canada, Hong Kong, New Zeeland, Singapore or South Africa or any other country or jurisdiction imposing such legal restrictions, you must click "No, I decline" below.

This content needs to be approved before viewing.
Yes, I accept
No, I decline